Health Professional Radio - Podcast

Dr. Karim Richard Masri, a Rheumatologist at the Bon Secours Rheumatology center in Richmond, VA discusses new data released by Horizon Therapeutics at the Annual European Congress of Rheumatology (EULAR 2020) that shows the benefit of combining immunomodulators with KRYSTEXXA® (pegloticase injection) to help more people with uncontrolled gout achieve complete and durable responses. Other data shared at EULAR addressed the rate of amputation reinforcing the systemic and potentially devastating impact of uncontrolled gout. Dr. Masri also discusses details for prescribers on how to ensure patients are supported during COVID-19.